Answers are grounded in this paper and cite their sources.
In this issue of Blood, Cooke et al demonstrate the potential of a fully human anti-hepcidin antibody as a novel therapeutic for iron-restricted anemias such as anemia of inflammation, cancer, or chronic kidney disease (formerly known as “anemia of chronic diseases”).
No takes yet. Share an insight, caveat, or question.
Elizabeta Nemeth (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: